Professor at the College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Canada. Former Member of the Canadian Drug Expert Committee and the Manitoba Drug Standards and Therapeutics Committee. Member of the PEBC Panel of Examiners for the Pharmacist Evaluating Examination. Board member of the Women's Health Research Foundation of Canada.
Dr. Abdulaziz Alzarea holds doctorate in Pharmaceutical Economics and Policy (Health Economics and Outcomes Research) and is currently serving as head of the Department of Clinical Pharmacy in Jouf University, Saudi Arabia. He has broad experience in Publishing related to Clinical Pharmacy, Pharmacy Practice, Pharmacoeconomics, Pharmacoepidemiology and outcomes research.
Dr. Mukund Chorghade is President and Chief Scientific Officer, THINQ Pharma / MVRC Research/ Chicago Discovery Solutions. He has had Adjunct Research Professor / Visiting Fellow / Scientists appointments at Harvard, MIT, Princeton, Cambridge, Caltech, Univ. of Chicago, Rutgers, Strathclyde and others. He provides synthetic chemistry and pharmaceutical development expertise to academic laboratories, pharmaceutical and biopharmaceutical companies. His research interests are in Traditional Medicine derived New Chemical Entities and the discovery of “chemosynthetic livers” that find utility in drug metabolism, valorization of biomass and environmental remediation.
Dr. Chorghade earned B. Sc. M. Sc. degrees from the University of Poona, and a Ph. D. at Georgetown University. He completed postdoctoral appointments at the University of Virginia and Harvard, visiting scientist appointments at University of British Columbia, College de France / Universite’ Louis Pasteur, Cambridge and Caltech and directed research groups at Dow Chemicals, Abbott Laboratories, CytoMed and Genzyme. He received three “Scientist of the Year Awards”, and is on the Scientific Advisory Board of several corporations / foundations. He is a Fellow of the ACS, AAAS, AIC and RSC, the Maharashtra, Andhra Pradesh and Telengana Academy of Sciences and has been a featured speaker in national and international symposia
Affiliation: Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland (Bacteriophage Laboratory).Position: professor.
Current field of interest: non-bactericidal effects of phages in mammals; i.e. phage molecular biology tools for studies of phage impact on immunological system and other physiological aspects in mammals.
Mainly involved in the discovery of new bioactive compounds from Antarctic and Arctic bacteria. Also working on on Antarctic psychrophilic microorganisms with potential biotechnological applications, and the dissection of the virulence determinants of some human pathogens by the use of non-vertebrate host model, like Caenorhabtidis elegans.
Dr. Subrata Deb is Chair & Associate Professor in the Department of Pharmaceutical Sciences at Larkin University, United States. Previous to this, he held positions at the Roosevelt University, The University of British Columbia and Tripura University.
Dr. Deb received his Bachelor of Pharmacy degree from the Berhampur University and his Master of Pharmaceutical Sciences from the University of Mumbai. He received his Ph.D. in Pharmaceutical Sciences from The University of British Columbia and subsequently completed his postdoctoral fellowship from the Vancouver Prostate Centre, a National Centre of Excellence.
Dr. Deb’s primary research interests include Pharmacology, Toxicology, Pharmacogenomics, and Pharmacokinetics with special emphasis on Drug Metabolism and Drug Interactions.
Dr. Sherif Ashraf Fahmy obtained his B. Pharm with honors from the Faculty of Pharmacy, Cairo University, and his MSc (2015) and Ph. D. (2020) in Chemistry from The American University in Cairo. His Ph. D. was conducted in collaboration with the Department of Pharmaceutics & Biopharmaceutics, Faculty of Pharmacy, Philipps-Universität Marburg, Germany. Dr. Fahmy was selected as one of the first recipients of the prestigious and very competitive fellowship offered by the Alfi Foundation for Ph.D. students. He has also spent time as a Visiting Scholar at the Department of Pharmaceutics and Biopharmaceutics, Faculty of Pharmacy, Philipps University of Marburg, Germany, in 2018.
He has received several other awards and recognitions, most notably, the Royal Society of Chemistry (RSC, UK) Travel Grant for Ph.D. students & Early Career Scientists in 2019, the Fulbright Scholarship at Ohio University in 2019, USA, and the Mobility Grant to participate in the Research Opportunity Week (ROW) organized by the Technical University of Munich in 2022. Dr. Fahmy has published several peer-reviewed articles in international journals and many abstracts at local and international conferences (H- index of 15). Dr. Fahmy’s research focuses on exploring novel herbal medicine, extracting and characterizing their major active ingredients, and investigating their anticancer activities. In addition, Dr. Fahmy’s research encompasses the design, physicochemical characterization, and biological evaluation of innovative targeted and functionalized drug delivery systems to treat cancer effectively. These systems are based on several nanomaterials, including but not limited to polymeric nanoparticles, naovesicles (niosomes, liposomes, bilosomes, etc.), supramolecular nanocontainers (calixarenes, cucurbiturils, cyclodextrins), and metallic nanoparticles.
Also, Dr. Fahmy is a member of the Royal Society of Chemistry (MRSC), the American Chemical Society (ACS), and ESMO. Also, he serves as a reviewer for many international journals. Dr. Fahmy is a full-time Assistant Professor of Chemistry at the School of Life & Medical Sciences, University of Hertfordshire, Egypt Campus. Also, he is the Head and Founder of the Herbal Medicine & Nanotherapeutics research group at the same university.
Dr. Liang Gao currently works as a senior Research Fellow at the Center of Experimental Orthopaedics, Saarland University, Germany. His clinical interests include sports medicine, arthroplasty, and traumatology. His research focuses on joint preservation and orthobiologics.
Dr. Gao studied Medicine in China and Germany with intensive fellowship training in both Asia and Europe. He completed the Musculoskeletal Surgical Oncology residency training at Peking University Medical Center, China. Moreover, he obtained his master of science degree (Radiation Oncology) from Heidelberg University, Germany and his doctorate (Biological Therapy) summa cum laude from Saarland University, Germany.
Dr. Gao is the Member of the Basic Science Committee of International Cartilage Regeneration & Joint Preservation Society (ICRS), the Member of the Early Career Investigator Committee of Osteoarthritis Research Society International (OARSI), and the Founding Member of the Sino Euro Orthopaedics Society (SEOS).
Professor of Vascular Pharmacology, University of Oxford and Fellow and Tutor in Medicine, Magdalen College, Oxford. Visiting Professor at the University of Queensland, Australia. Previously, Head and Professor of Pharmacology, University of Bath and Professor of Cardiovascular Pharmacology, University of Bristol. Visiting Professorships; University of Nagoya, Japan, Monash University, Australia and the National Academy of Sciences, Taiwan.
Jeremiah's research focuses on several areas:
Development of stimuli responsive "smart" biomaterials
Creating new thermosalient molecular crystalline materials
Using metal-organic frameworks for native protein (i.e. drug) delivery
Supramolecular and macromolecular organic radical contrast agents as MRI sensors
Dr. Mahesh Gokara is a Postdoctoral Research Fellow in the Department of Cancer Biology at the Mayo Clinic. He has a Ph.D biochemistry with an experience of over 10 years in multidisciplinary research areas including biochemistry, biophysics and bioinformatics.